MiR-378 exaggerates angiogenesis and bone erosion in collagen-induced arthritis mice by regulating endoplasmic

Zhengmeng Yang1,2,3, Nan Hou2,3, Wenxiang Cheng4

  • 1Centre for Regenerative Medicine and Health, Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences, Hong Kong SAR, PR China.

Cell Death & Disease
|December 18, 2024
PubMed

Insights

MicroRNA-378 (miR-378) accelerates rheumatoid arthritis (RA) by increasing endoplasmic reticulum stress, angiogenesis, and osteoclastogenesis. Inhibiting miR-378 shows promise for treating RA.

Area of Science:

  • Immunology
  • Molecular Biology
  • Pathology

Background:

  • Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting synovial joints.
  • MicroRNA-378 (miR-378) is upregulated in RA patients and linked to disease severity.
  • The precise role and mechanisms of miR-378 in RA pathogenesis are not fully understood.

Purpose of the Study:

  • To investigate the function of miR-378 in rheumatoid arthritis development.
  • To elucidate the molecular mechanisms underlying miR-378's role in RA.
  • To evaluate miR-378 as a potential therapeutic target for RA.

Main Methods:

  • Utilized miR-378 transgenic (miR-378high) mice to model collagen-induced arthritis (CIA).
  • Assessed joint swelling, bone deformities, endoplasmic reticulum (ER) stress markers, angiogenesis, and osteoclastogenesis.
  • Identified Crebrf as a downstream target of miR-378 and tested anti-miR-378 lentivirus therapy.

Main Results:

  • miR-378high CIA mice exhibited accelerated RA with enhanced joint inflammation and bone damage.
  • Increased ER stress, angiogenesis, and osteoclastogenesis were observed in miR-378high mice.
  • miR-378 promotes RA by upregulating ER stress, angiogenesis, and osteoclastogenesis via Crebrf; anti-miR-378 therapy ameliorated RA progression.

Conclusions:

  • miR-378 exacerbates rheumatoid arthritis by promoting ER stress, angiogenesis, and osteoclastogenesis.
  • The ER stress-related protein Crebrf is a key mediator of miR-378's pro-RA effects.
  • Targeting miR-378 represents a potential therapeutic strategy for rheumatoid arthritis.